We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRST
14301
DELISTED
Presto Technologies, Inc. Common Stock
PRST
-15,599
Closed -$158K
FREE
14302
CALL
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
-11,400
Closed -$82K
BTCY
14303
CALL
DELISTED
Biotricity, Inc. Common Stock
BTCY
-2,783
Closed -$38K
SDPI
14304
DELISTED
Superior Drilling Products Inc.
SDPI
-32,324
Closed -$34K
BTEC
14305
DELISTED
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
-9,307
Closed -$369K
SBOW
14306
DELISTED
SilverBow Resources, Inc.
SBOW
-53,074
Closed -$1.94M
VNMC
14307
DELISTED
Natixis Vaughan Nelson Mid Cap ETF
VNMC
-6,806
Closed -$216K
HOLI
14308
PUT
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
-30,000
Closed -$479K
NFYS.WS
14309
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
-295,292
Closed -$82K
NFYS
14310
DELISTED
Enphys Acquisition Corp.
NFYS
-588,700
Closed -$5.67M
TRTL
14311
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
-1,116,326
Closed -$10.8M
BHIL
14312
DELISTED
Benson Hill, Inc.
BHIL
-2,284
Closed -$269K
SEPAW
14313
DELISTED
SEP Acquisition Corp Warrants
SEPAW
-275,126
Closed -$91K
SEPA
14314
DELISTED
SEP Acquisition Corp Class A Common Stock
SEPA
-550,253
Closed -$5.4M
SHPW
14315
PUT
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
-2,750
Closed -$63K
VCXB
14316
DELISTED
10X Capital Venture Acquisition Corp III
VCXB
-750,000
Closed -$7.46M
ASLN
14317
PUT
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
-300
Closed -$11K
TCON
14318
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-2,487
Closed -$96.3K
MODN
14319
CALL
DELISTED
MODEL N, INC.
MODN
-14,400
Closed -$387K
HGAS
14320
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
-53,124
Closed -$528K
ADTH
14321
DELISTED
AdTheorent Holding Co
ADTH
-28,800
Closed -$283K
APCA.WS
14322
DELISTED
AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
APCA.WS
-201,054
Closed -$52K
TGAN
14323
DELISTED
Transphorm, Inc. Common Stock
TGAN
-54,397
Closed -$385K
AONCW
14324
DELISTED
American Oncology Network, Inc. Warrant
AONCW
-256,890
Closed -$102K
GRTX
14325
PUT
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
-59,900
Closed -$143K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.